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ABSTRACT  
This systematic review assesses the long-term effectiveness of weight loss on all cause mortality in 
overweight/obese people. Medline, Embase and Cinahl were searched (1966–2005). Cohort studies and 
trials on participants with Body Mass Index ≥25 kg/m2, with weight change and mortality with  ≥ 2 years 
follow-up were included finally identifying 11 papers based on 8 studies. There may be gender differences in 
the benefits for all cause mortality.  The impact of weight loss in men on mortality was not clear with some 
studies indicating weight loss to be detrimental, while a recent cohort study showed benefits, if it were a 
personal decision. Other studies with no gender separation had similarly mixed results.  However, one study 
indicated that overweight/obese women with obesity related illness, who lost weight intentionally within one 
year, had significantly reduced mortality rates of 19% -25%.  In contrast, studies of overweight/obese 
diabetics irrespective of gender, showed significant benefit of intentional weight loss on mortality in a meta-
analysis, HR=0.75(0.67- 0.83). There is some evidence that intentional weight loss has long-term benefits on 
all cause mortality for women and more so for diabetics. Long-term effects especially for men are not clear 
and need further investigation. 
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Introduction 
Obesity is now considered a global epidemic. In the last two decades there has been an alarming rise in 
obesity with one third of the population in the United States being affected.(1) Similar trends have been 
noticed in Europe. Obesity induces multiple metabolic abnormalities leading to diabetes mellitus and 
cardiovascular disease and is associated with increased disability, morbidity and mortality.(2-5) 
 
Previous reviews of weight loss studies have reported that moderate weight losses (losses of 5-10%) are 
associated with improvements in obesity related cardiovascular and metabolic abnormalities.(6-9) It might be 
expected that this in turn will reduce mortality in the long-term. In recent years, the relationship between 
weight loss and mortality has raised concerns with studies reporting increased mortality with weight 
loss.(10;11) It is still unclear, however, whether weight loss in overweight/obese people, either voluntary or 
involuntary, truly reduces mortality.(12;13) 
 
The aim of this paper was to systematically review the available evidence on the relationship between weight 
loss in overweight/obese adults and long-term all cause mortality. The intentionality of weight loss and 
gender differences were also explored in this paper. 
 
Research Methods and procedures 
A systematic literature search was undertaken on Medline, Embase, Cinahl electronic bibliographic 
databases. The review included literature published between 1966 and October 2005 with no language 
restrictions.  Mesh terms and text words for ‘cohort studies’, ‘obesity’, ‘ overweight’, ‘weight changes’ and 
‘mortality’ were used and appropriately combined.  The inclusion criteria covered all prospective studies and 
trials carried out on participants with body mass index (BMI) of greater than, or equal to, 25 kg/m2.  Initially 
those with BMIs of ≥28 were considered since overweight people on the verge of obesity may also 
experience some of the hazards of obesity.  However, due to paucity of studies that met that strict criteria, 
studies with overweight and/or obese sub-groups (BMI≥25) were also deemed suitable.   Cohort studies and 
randomised controlled trails (RCTs) with weight change measurements, mortality information and a follow-up 
of more than 2 years were included. 
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Participant criteria included adults between 18 and 70 years. After 70 years of age weight loss may be 
confounded with age.(14) Studies on Caucasian, Afro-American, Japanese American and British Asian 
populations were included in the review. It should be noted that the ethnic minorities in western cultures may 
adopt the culture and dietary habits of their Caucasian counterparts and may, therefore, have similar risks of 
obesity.  General population studies, animal studies and studies with less than 40% follow-up were excluded.  
 
To identify relevant studies, abstracts were divided up and read by two independent reviewers. Full articles 
of the studies that met our selection criteria were obtained, and initially assessed by two independent 
reviewers, and then by one reviewer for methodological quality. Reference lists of all studies and review 
articles included were also checked to identify other relevant studies.  A data extraction form was designed, 
piloted and amended before being used by two independent reviewers to extract the data from the papers. 
Researchers consulted regularly with each other to discuss any inclusion queries as they arose. Where 
relevant and possible, authors were contacted for further information about studies not available from their 
published papers. 
 
Measures of mortality in all the papers were reported as either relative risk (RR) or hazard ratios (HR). 
Attempts were made to combine the studies using meta-analysis (methods described by Sutton et al.(15)) 
when the studies had comparable interventions, settings and test statistics.   
 
Results 
In total 8089 abstracts were scanned, and 301 full articles were obtained and critically appraised, of which 11 
papers (16-26) published from 8 studies investigated the effects of weight loss on all cause mortality.  The 
characteristics and details of the studies and papers are described in Table 1.  
 
  (Table 1 here) 
 
On investigation the results were grouped and presented as the effects of weight loss on mortality for studies 
presenting only women and only men; other studies combining results for both men and women with no 
gender separations  and finally for studies reporting on those with Type 1 or Type 2 diabetes.  
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Within the results, the effects of intentionality of weight loss is also presented where intentionality was 
assessed and reported by the authors of the included studies as part of their results.   
 
Results for women only  
Two papers (21;24) reported mortality with weight loss for US white women.  Rumpel (21) used the US 
NHANES cohort, recruited in 1971, using information up to but not including the 1992 wave of data.  The 
other paper was by Williamson (24) using women recruited in 1959 from the US Cancer Prevention Study 
(CPS-I) monitoring weight in 1960-5 and deaths up to 1972.   Both these cohorts involved people with similar 
average ages spanning mid 40s to mid 50s for ‘initial’ weight (Table 2).  It should be noted that the NHANES 
cohort used the maximum life time weight assessed retrospectively. 
 
(Table 2 here) 
 
Results from the Rumpel (21) study showed significantly increased mortality for all overweight/obese people 
with weight loss.  After excluding the first 5 years of deaths this was still true for those with losses of  ≥8.55% 
of body weight.   In this study, however, the reference group were those of normal weight with small weight 
loss.   The other study by Williamson (24) on the other hand only investigated women who were at the very 
least over weight.  Here they asked about weight loss intention and also about any obesity related illness 
and in each case used the ‘No weight change’ sub-group as the reference group .  For those with illness and 
intentional weight loss the mortality risk significantly improved when referenced to similar people with no 
weight change, except for those with weight loss <20 pounds and who took longer (1 or more years) to lose 
the weight.    
 
The non-comparable reference groups in the Rumpel study leaves only the Williamson study on which to 
base any conclusions. This indicates some benefit for women with obesity related illness and intentional 
weight loss. Meta-analysis was therefore inappropriate in this case with only one study. 
 
Results for men only  
Three papers (20;23;25) were reviewed for men only. The Williamson paper was again a sub-group analysis 
of the CPS-I cohort (25) (recruited in 1959, recordings 1960-5, deaths until 1972).  Nilsson (20) reported on 
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the Swedish Malmo Preventative Project (MPP), where men were screened in 1974 and 1982, with deaths 
being followed up to the end of 1999.  Data from the British Regional Heart Study were analysed by 
Wannamethe (23), recruited in 1978-80, re-measured in 1992-6 with intentionality asked about retrospective 
weight changes in 1996 and deaths monitored up to October 2003.  Two of the studies (20;25) had similar 
age means (mid 40s to mid 50s) while Wannnamethee (23) included men up to 75 years old (Table 3).  
 
(Table 3 here) 
 
Considering men of the CPS-I cohort, Williamson (25) used the same format as women discussed in the 
previous section whereby the participants were all at least overweight.  Once again the intention of weight 
loss and those with and without health conditions were subdivided.  Despite the comparable reference group 
of weight stable men, those with intentional weight loss (if carried on for longer than 1 year) was detrimental 
for all men, except if it was <20 pounds for those with some health conditions.  Unintentional weight loss was 
also marginally detrimental.  
 
Nilsson (20) also reported weight loss as being detrimental, for non cancer mortality, when compared to 
similar men who were weight stable (Table 3) although  intentionality was not reported. These men were not 
ill despite being overweight/obese giving comparable results for the similar group described by Williamson.  
 
The analysis on overweight men by Wannamethee (23) was adjusted for several variables accounting for 
demographic variations and probably underlying ill health. The men in this study showed that compared to 
the weight stable sub-group those with intentional weight loss (if a personal decision) was extremely 
beneficial, although it made no difference if the men were ill and or told to lose weight by their doctor.   
 
Overall the impact of weight loss on mortality in men is not clear.  Two studies (20;25) indicate weight loss to 
be detrimental while the most recent cohort (23) shows clear benefits if the loss is a personal decision. When 
all papers are combined using a random effects meta analysis model, then compared to the reference group 
in each study of overweight weight stable men, the overall effective weight loss is slightly detrimental with a 
Hazard Ratio of HR=1.15(1.08, 1.01). Combination of pairs of studies as a sensitivity analysis did not alter 
this finding unless Williamson’s study was excluded when it became non significant with wide confidence 
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intervals. When studies with only intentional weight loss are considered, then the hazard ratio as a fixed 
effect model, becomes non-significant, HR=1.01(0.99,1.09). 
 
Results for men and women combined studies 
Mortality and weight loss for obese men and women together, with no gender separation was reported in 
three papers (17;18;22) detailed in Table 4.  Gregg 2003 (18) used the National Health Interview Survey 
(NHIS) conducted in 1989 with self reported intention of weight loss and vital status followed for 9 years.  
Christou 2004 (17) reported  two Canadian cohorts running together between 1986 and 2002, where one 
cohort had surgical interventions while the other acted as a standard treatment control group. Sørensen 
2005 (22) reported on the Finnish twin cohort for men and women born before 1958, still alive in 1967 with 
self-reported measures in 1975 along with attempts to lose weight (defined as intention) and weight change 
noted in 1981 where mortality was recorded up to 1999.    
 
(Table 4 here) 
 
All three papers cover a similar era with mortality being recorded from the mid-eighties to the millennium 
although the participants of Gregg’s paper from the NHIS study (18) were about a decade older so that the 
average age varied slightly between the studies, 40 up to 57 years old. 
 
The analysis from Gregg’s (18) study adjusted for more than 13 variables, including demographic variables 
but also attempted to account for known underlying illnesses. Of all those who were not trying to lose weight, 
people who actually gained had a marginally beneficial effect with respect to mortality, when compared to 
those who were weight stable. When smokers were excluded this benefit disappears indicating that despite 
being adjusted for, smoking had remained influential in the original model.  In this group trying not to lose 
weight, those with small amounts of weight loss saw no significant mortality rate differences while larger 
weight losses were seen to be detrimental.  In contrast, for those who claimed to be trying to lose weight the 
effects were marginally beneficial if they remained weight stable or lost small amounts, the latter remaining 
significant even when the smokers were excluded.   
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Another recent study reported by Sørensen (22) also considered intentional weight loss adjusting for 
demographic and lifestyle variables.  Unlike the Gregg paper, weight gain for those not intending to lose 
weight was seen here to be detrimental.  It was observed that even for those with intentional weight loss the 
effect was also detrimental.   
 
Christou (17) considered very different individuals, all morbidly obese. In this surgical cohort 7/1035 died 
(losing an average of approximately 33kg) compared to those under standard treatment where 354/5746 
died (weight loss not recorded).  The results provided are relative risks as well as Kaplan Meier survival 
analysis although without any obvious adjustments.  Usually surgery is only considered for those for whom 
obesity is life threatening.  Consequently, the surgery group does have a substantially reduced mortality risk 
compared with the similar control group who do not undergo surgery.  Similarly, the effects of the surgery are 
difficult to disentangle from any weight loss benefits for this sub-group.  Weight loses possible with surgery 
are enormous and for this study were between 60-80% of the excess weight 2-5 years after surgery.   
 
In this section, Christou had a completely different approach, weight management being a surgical 
intervention.  Although, the paper claims that the participants had no other pre-existing illness it is likely that 
they would initially have had a high risk of mortality.  The other two papers, however, were comparable 
(18;22) when considering their interventions analyses and the fact that the reference group was 
‘overweight/obese weight stable and not trying to lose weight’.  This it possible to consider meta-analysis. 
When all sub-categories from these two papers(18;22) were combined using a random effects model, the 
result was a non-significant hazard ratio of HR= 1.06 ( 0.83, 1.34).   Assuming that hidden pathology is more 
likely to be a confounding factor for those who lost weight without trying, meta-analysis was also conducted 
on just the intentional weight stable/loss sub-categories as a sensitivity analysis.   However, the hazard ratio 
of HR=0.93 (0.71, 1.22) was still non-significant.  
 
 
 
Results for overweight/obese people with Diabetes Mellitus  
The consideration of weight loss for overweight/obese individuals also suffering from diabetes mellitus was 
presented by Williamson and Gregg as sub-groups of two American studies already described in this review: 
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the CPS-I cohort (26) (recruited 1959,  recordings 1960-5, death 1972) and NHIS conducted in 1989 (19) 
and followed for 9 years.  Another paper by Chaturvedi (16) reporting on the WHO MSVDD cohort (recruited 
in 1975-7, measurement follow-up 1983-8, and mortality reported until 1988) also considered those with 
Type 2 diabetes mellitus  for overweight and obese individuals separately.  While this latter cohort and paper 
includes international data, only the results on the European cities are extracted for this review.  The 
Chaturvedi study (16) had smaller undetermined sample sizes for these sub-groups of patients and had 
slightly younger participants.  
 
(Table 5 here) 
 
The studies overall, described in Table 5, give mixed results.  When weight loss intention had been defined, 
then diabetic obese people seem to benefit from losing weight, although, it should be noted that the two 
papers (19;26) that illustrate this also adjusted for multiple diabetic related variables both reporting their 
results as hazard ratios.  In contrast, the European analyses from Chaturvedi (16), indicate that weight loss 
was detrimental for those who were diabetic and overweight having adjusted for only age, sex and duration 
of diabetes.  This latter study had no definition of intention of weight loss and had small sample sizes . 
 
 
A combined meta analysis of all the studies using a random effects model indicates a non-significant  
hazard ratio of HR= 0.91 (0.70, 1.18).  This non-significant finding was not effected when combination of 
pairs of studies as a sensitivity analysis was conducted.  As before, hidden pathology may well be a 
confounding factor justifying the removal of unintentional weight loss groups.  On this occasion, the reduced 
analysis from the Williamson and Gregg (19;26) papers only using ‘weight stable and not trying to lose 
weight’ was the referent for all analyses , shows a significant beneficial effect, HR=0.75 (0.67, 0.83), of 
intentional weight loss for overweight/obese participants with diabetes.   
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Discussion  
This review aims to determine long-term effectiveness of weight loss on all cause mortality. Gender 
differences and the impact of co-existing illness have been identified as important, along with the notion of 
intentionality of the weight loss.  With respect to gender, for studies with men only (20;23;25) and those that 
report men and women together (18;22), the effects of weight loss on mortality were inconsistent regardless 
of intentionality.  An investigation into overweight/obese women with pre-existing obesity related illness on 
the other hand resulted in a benefit from intentional weight loss albeit that this conclusion was based on only 
one paper (24).  This latter finding raises the question of whether gender differences exist.  However, 
irrespective of gender, those suffering from diabetes, another common obesity related illness, had benefits 
with intentional weight loss (19;26). 
 
If there is a gender divide as suggested by our review, this could be a result of women being more frequent 
visitors to healthcare. Studies have shown that there are significant differences in the ways men and women 
seek medical attention for health.(27)  Men tend not to seek early medical attention compared to women, 
and this in turn leads to poorer health outcomes.(28;29) However, from this review a personal decision by 
men to lose weight may be beneficial. Otherwise, hidden pathology may go undiagnosed in men more easily 
than in women, particularly for cancers, which are often initially asymptomatic.  The decrease in mortality for 
those with diabetes could also be attributable to early healthcare advice as a direct result of the more 
obvious diabetes symptoms, particularly in men.  
 
 
There have been recent reviews investigating effects of weight change on mortality. However, these reviews 
assessed the outcomes on the general population (30;31) or focused on specific outcomes. (12)  Evidence 
has shown that there are benefits of weight loss in the short-term but that the sustainability of these benefits 
in the long-term are debatable. (32)  In relation to the general population, the risk of morbidity and mortality is 
higher for those who are overweight/obese.  Consequently, our review on ‘all cause mortality’ addressed 
these issues collectively by focusing on the available long-term (more that 2 years) evidence specifically for 
the overweight/obese populations. 
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Many methodological limitations were identified in the included primary studies relating to either study design 
and/or statistical issues.  These in turn had an impact on the findings and conclusions drawn in this review. 
Potential bias is inevitable with retrospective studies with recall and self-reporting measure of outcomes 
including those of weight.  This potential bias affected the majority of the included studies except that by 
Chaturvedi (16) conducted among diabetic patients and the surgical study by Christou (17) both conditions 
which usually have close monitoring.  Any conclusions about gender differences have been limited in this 
review since one of the two studies on women compared overweight/obese women who lost weight to a 
referent group who were normal/stable weight and therefore not directly comparable.  Our review has 
confirmed a key concept of intentionality of weight loss as suggested by others.(33)  Even when intention 
has been expressed, there may well be other proximal factors that led to the weight loss that needs to be 
disentangled. (34)  
 as interpreted by the authors of each study with no specific definition, which raises a query about 
consistency. Pooling of evidence, based on meta-analyses, in order to make robust conclusions was 
restricted given the varying methodology and test statistics quoted and those with comparable results often 
had multiple and/or different model adjustments. 
 
Considering the limitations and the aims of this review, benefits of weight loss on all cause mortality for 
overweight/obese populations is meagre.  Possible explanations for this are many and varied, the most 
important being intentionality, self reporting of weight loss and the time lapse between last recorded weight 
loss measurement and the mortality outcome. Recent discussions (35-37) display the variety of controversy 
on intentional weight loss benefits on all cause mortality.  Although for mortality studies, the follow-up is long-
term, patterns of weight change such as weight cycling in between the study measures and death are 
usually not accounted for. (22) Most recently the concept of weight loss type (such as fat-free vs fat) seems 
to have an impact on all cause mortality. (36;38-40) These indicate that even for intentional weight loss 
programs, the type of weight loss may be important for this ultimate health outcome.  
 
The highlighted issues of intentionality, type of weight loss and objective measurements of weight changes 
still need to be investigated in well designed prospective studies to assess the real impact  of weight loss on 
all cause mortality in the long term for overweight/obese populations.  Given that mortality studies are 
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generally long-term, consistent follow-up of measurements of weight change would further strengthen 
results. 
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Table 1: Basic characteristics of included studies  
Author/year/country Study + Description of sample  Mortality record 
Follow-up 
Follow-up Time 
Rumpel 1993 (21) 
White Women 
USA 
White Women 
NHANES I (1971-4) interviews and examinations. Followed up by NHEFS (1982-4)     
n= 14,407, with two follow-up waves until 1987, when they were measured and asked what and 
when their maximum weight was.   Included those 65-74 years old in 1982-4, however at 
maximum weight participants were Mean (sd) Age of 54 (14) years old. 
Excluded small numbers of non-white, missing data for height, missing max lifetime weight 
leaving n=1450 
1554 deaths of which  
97.5% had death 
certificates  
Median follow-up 13.6 
years for Survivors 
Williamson  1995 (24) 
USA 
never smoking, over 
weight white women 
Included overweight, never smoking, white women  
Excluded those who died in first 3 years of follow-up 
No pre-existing disease n=28,388 
Obesity related illness n=15,069 
91.0% complete 
mortality follow-up 
survivors 12 years  
decedents 7.5 years  
Williamson 1999 (25) 
USA 
White men 
Included initial BMI>27 white men with data on weight (change, 
direction, time and intent), current health and without pre-existing 
cancer or other disease.  
No health condition n=36,280  
With health problems n=13,057 
91.0% complete 
mortality follow-up 
12 years 
survivors 12.9 years  
decedents 7.3 years  
Williamson 2000 (26)  
USA 
Diabetic patients 
Prospective cohort: 
overweight recruited in 
1959 from Cancer 
Prevention Study CPS-I 
(n=1,078,894).  
Vital status determined 
annually 1960-5. 
 
Weight change asked 
about retrospectively 
along with intention 
 
Aged 40-64 at baseline 
 
Death certificates 
recorded 1971-2.   
Excluded missing data on weight (change, direction, amount and 
intent), smoking, alcohol education physical activity and race  
Overweight, with diabetes n=4,970 
91.0% complete 
mortality follow-up 
12 years 
survivors 12.9 years  
decedents 7.1 years  
Chaturvedi 1995 (16) 
European Results: Men 
and women with Type 2 
Diabetes Mellitus 
Cohort Study- World Health Organization Multinational Study of Vascular Disease in Diabetes 
(WHO MSVDD) 14 centres in 3 geographical areas. 
European included London, Switzerland, Berlin, Warsaw and Zagreb 
Base exams 1975-7, Aged 35-55 years old, morbidity and height and weight follow up 1983-8.  
Mortality until 1988  
European BMI>25 with NIDDM: men n=445; women n= 507. 
However, only n=581 with initial weight, weight change and mortality. 
95% mortality records 
complete.  But 
proportion with weight 
change data & 
mortality 
848/1,446=58.64% 
unknown for after 
weight change  
> 6 years for whole 
study 
Nilsson 2002 (20) 
Sweden  
Overweight, obese 
otherwise healthy men  
 
Malmo Preventative Project (MPP) 5722 men screened twice 1974 and 1982.   
Interventions: Lifestyle and drug.  
Physical exam at base and follow-up.  Self questionnaire on smoking, nervous, weight changes 
and health.  Aged 38-52 years old at baseline 
Mortality register recorded up to Dec 1999 
Excluded those with prevalent disease at base, cancer, died in 1st year and missing weight 
change information. n=5194,  with 571 deaths  
    6 years for weight
change average 
 22 years for whole 
study 
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Gregg 2003 (18)  
USA 
Overweight or obese  
Mean Age 54.2 years old  
Excluded:   BMI < 25 before weight loss, <35 years 
old, any with missing data: hence n=6391 
98% for vital status 
Gregg 2004 (19) 
USA 
Overweight or obese 
diabetic patients  
The National Health Interview Survey 
(NHIS) + supplemental survey 
conducted in 1989 with self reported 
intention of weight loss n=20,847.  Vital 
status followed for 9 years: n= 20,439  
Selected those ≥ 18 yrs old with diabetes n=2531 
linked n=2459 to death register 
Mean Age 16.2 years old 
Excluded:   BMI < 25 before weight loss and any with 
missing data: ie n=1,401 
97% for vital status 
9 years after weight 
change 
(Mean 8 years) 
Christou 2004 (17) 
Canada 
Men and women  
2-cohort study: 1986-2002 ie surgery vs 
control groups 
7 different surgeons, 3 type of surgery; 
RY isolated gastric bypass (79.2%); 
VGB (18.7%) laporoscopic RY (2.2%) 
 
Bariatric surgery (n=1035) vs  Matched (age, gender) 
morbidly obese controls (n=5746)  
[6 controls for every bariatric surgery].  
Those with medical conditions other than obesity 
were excluded. 
Mean (sd)  Age Surgery group 45.1 (11.6) 
                          Control group 46.7 (13.1) 
100% of mortality 
records for both 
cohorts 
Measurement follow 
up ≈82% up to 5 
years  
Max of 5 years 
Bariatric surgery 2.5 
(sd=1.4) years 
Controls  
2.6 (sd=1.5) years 
Wannamethee 2005 
(23) 
Britain  
Men 
Prospective Study: British Regional Heart Study, 24 British towns; Men aged 40-59 at 
recruitment.  1978-80 questionnaire height and weight, smoking, alcohol, physical activity and 
med history; A similar questionnaire to survivors in 1992 and 1996. Later also asked for 
intentional and unintentional weight loss over preceding 4 yrs. 5265 survivors, 5267 completed 
1996 questionnaire and 4869 men age 56-75 years provided weight change data in 1996 
questionnaires.  Mortality recorded up to Oct 2003.   
Excluded 83 with fluctuating weight leaving 4786 with weight loss.   
In 1992 the cohort had BMI<28 n=3613 and BMI ≥ 28 n=1061 
99% of cohort 
 
7 years 
 
Sørensen 2005 (22) 
Finland 
Men and women 
The Finnish Twin Cohort: same sex twin born before 1958 and both still alive in 1967.  
(n=19,993) in 1975 self-reported height, weight, lifestyle and current attempts to lose weight 
(intention).  1981 current weight, Ages 24-60 years.  Only those BMI ≥ 25 at base considered 
here (n=4,466).  Mortality recorded up to 1999 
Exclusions: Any with (pre-)existing disease between 1972-82, not working any missing data 
ie. n=2,957 of which 2,067 did not have a co-twin, any within-pair correlation of phenotypes 
adjusted for. 
89% of those eligible 
responded in 1975. 
91% of those still 
alive then responded 
in 1981 
18 years after 
recorded weight 
change 
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Table 2: Mortality rate ratios – Women (The reference group is highlighted for each study)   
Age All cause Mortality Author year Status Group of interest 
     Mean    (sd)     
Sample
size 
Deaths rate ratios (95%CI) 
All deaths      
BMI<23 weight loss <8.55% 44 II (18) 364 197 1  (RR adj 2 vars) 
BMI 26-29 weight loss <8.55% 1.20 (0.80, 1.80) † 
BMI 26-29 weight loss ≥8.55% 56
 II (13)  363 163 1.90 (1.30, 2.90) † 
BMI≥29 weight loss <8.55% 1.50  (1.00, 2.30) † 
BMI≥29 weight loss ≥8.55% 58 
II (14)  
    
362 185 2.30  (1.50, 3.40) † 
 Exclude first 5 year follow-up deaths □ 
BMI<23  weight loss <8.55%  - - - - 1  (RR adj 2 vars) 
BMI 26-29 weight loss <8.55% (5yr) - - - - 1.10 (0.70, 1.70) 
BMI 26-29 weight loss≥8.55% (5yr)  - - - - 1.80 (1.20, 2.80) † 
BMI≥29 weight loss <8.55% (5yr) - - - - 1.40 (0.90, 2.20) 
Rumpel 1993  
Women ‡ (21)
 
 
Unknown 
weight change  
intention and 
illness status 
 
BMI≥29 weight loss≥8.55% (5yr) - - - - 2.10 (1.30, 3.40) † 
No weight change 52.2 (6.5) 14,093 755 1  (HR adj 6+ vars) 
Unintentional weight loss  52.9 (6.6) 942 67 1.20 (0.93, 1.55)  
Intentional weight loss of <20lbs  51.7   (6.3) 2,745 156 1.12 (0.94, 1.33)  
under 1 year - - - 116 1.05 (0.86, 1.28)  
1 or  more years - - - 40 1.40 (1.02, 1.93) † 
Intentional weight loss of >20lbs 50.8   (6.4) 3,018 156 0.98 (0.82, 1.17) 
under 1 year - - - 65 0.77 (0.59, 1.00) * 
No pre-
existing illness 
1 or more years - - - 91 1.22 (0.98, 1.53)  
No weight change 54.1 (6.4) 7,494 1,038 1  (HR adj 6+ vars) 
Unintentional weight loss 55.3 (6.1) 812 136 1.00 (0.83, 1.20)  
Intentional weight loss of <20lbs  53.8   (6.3) 1,550 175 0.80 (0.68, 0.94)  * 
under 1 year - - - 128 0.75 (0.62, 0.90) * 
1 or more years - - - 47 0.98 (0.73, 1.31)  
Intentional weight loss of >20lbs  53.7   (6.3) 2,598 341 0.81 (0.71, 0.92) * 
under 1 year - - - 158 0.78 (0.66, 0.93) * 
Williamson 
1995(24)  
Overweight, 
never smoking, 
white women § 
 
Obesity 
related illness 
1 or more years - - - 183 0.84 (0.71, 0.99) * 
 
* Significant decrease (p≤ 0.05); † Significant increase (p≤ 0.05); -  Not Available Data 
‡ Proportional hazard model to obtain Relative Risk adjusted for 2 variables: age and smoking.  
§ Proportional hazard model adjusted for 6(+?) variables: age at base, initial BMI, education, alcohol consumption, physical activity, and all health conditions.  Deaths in first 
three years excluded. 
II Mean age at maximum weight; (HR) Hazard ratio; (RR) Relative Risk; (adj n vars) adjusted for n covariables 
□ Sample sizes, deaths and summary statistics unknown for this reduced group
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Table 3: Mortality rate ratios – Men (The reference group is highlighted for each study) 
Age All cause Mortality 
Author year Status Group of interest 
     Mean     (sd) 
Sample 
size Deaths rate ratios (95%CI) 
No weight change  51.4 (5.9)  19,064 2558 1  (HR adj 7+ vars) 
Unintentional weight loss  52.0 (6.1) 1,474 234 1.04 (0.91, 1.19) 
Intentional weight loss of <20lbs  51.5 (5.8) 2,834 381 1.09 (0.98, 1.21) 
under 1 year - - - 273 0.98 (0.87, 1.12) 
1 or more years - - - 108 1.48 (1.22, 1.80) † 
Intentional weight loss of >20lbs 51.5   (5.9) 2,610 412 1.07 (0.96, 1.20) 
under 1 year - - - 226 0.98 (0.85, 1.13) 
No pre-existing 
illness 
1 or more years - - - 186 1.20 (1.03, 1.40) † 
No weight change 53.3 (6.0) 6,043 1,990 1  (HR adj 7+ vars) 
Unintentional weight loss 54.4 (6.3) 917 391 1.15 (1.04, 1.27) † 
Intentional weight loss of <20lbs  53.4   (5.9) 1,310 440 1.01 (0.91, 1.12)  
under 1 year - - - 327 0.99 (0.88, 1.11)  
1 or more years - - - 113 1.07 (0.88, 1.29)  
Intentional weight loss of >20lbs  53.6   (6.0) 2,614 1,098 1.02 (0.94, 1.11)  
under 1 year - - - 555 0.94 (0.85, 1.04)  
Williamson 1999 
(25) 
 
Overweight, 
white men ‡ 
 
With health 
conditions  
1 or more years - - - 447 1.13 (1.03, 1.26) † 
Stable 47.4 (2.6) 513 46 1  (RR adj 14+ vars) Nilsson2002 
(20)Swedish Men 
§ ** 
BMI ≥26  but healthy 
Decrease 47.1 (2.8) 482 71 1.71 (1.18-2.47) † 
No weight change:   426 99 1  (RR  adj 14+ vars) 
Unintentional weight loss:  108 40 1.48 (0.99, 2.21) 
Intentional weight loss                                     
(personal decision)  48 4 0.23 (0.06, 0.95) * 
Wannamethee 
2005: (23)British 
Men  
BM I≥ 28 II  
Random from GP 
registers in 1978. 
Illness not specified 
                             (Drs advice/ill health) 
Whole 
study 
56-75 
years old 
- 
82 19 0.97 (0.57, 1.64) 
 
* Significant decrease (p≤ 0.05); † Significant increase (p≤ 0.05); - Not Available Data 
‡ Proportional hazard model adjusted for 7(+) variables: age at base, initial BMI, smoking, education, alcohol consumption, physical activity, and all health conditions. 
§ Cox proportional hazard model to estimate Age adjusted relative risk for non-cancer mortality 
II Cox proportional hazard model to assess Relative risk adjusted for 14(+) variables: age, smoking, social class physical activity, current BMI, social class, perceived health 
status, history of hypertension, coronary heart disease, stroke, diabetes, other cardiovascular disease conditions and cancer 
** A split into smoking Y/N with overweight/obese combinations was available, but was univariate analysis with multiple testing  
(HR) Hazard ratio; (RR) Relative Risk; (adj n vars) adjusted for n covariables 
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Table 4: Mortality rate ratios – Men and Women (The reference group is highlighted for each study) 
Age  All cause Mortality Author year Status Group of interest 
Mean   (sd) 
Sample 
size 
Deaths rate ratios (95%CI) 
Control group  (36% men)  46.7 (13.1) 5746 354 1  (RR adj ? vars) Christou 2004 (17)  
Morbidly obese Men 
& women § 
No (other) pre-
existing illness 
Bariatric surgery group (34.4% men)  45.1    (11.6) 1035 7 0.11 (0.04, 0.27) * 
Not trying to lose weight (64.5% men) 56.3     - 2766 -
         Gain - - - - 0.62 (0.39, 0.99) †† 
          No weight change: - - - - 1  (HR adj 13+ var) 
           1-9 kg lost - - - - 1.05 (0.74, 1.49) 
           >9kg lost - - - - 1.72 (1.24, 2.38) † 
Trying to lose weight (47.9% men) 52.5     - 3625 -
          Gain  - - - - 0.95 (0.65, 1.38) 
          No weight change: (58.2% men) - - - - 0.81 (0.65, 1.00) †† 
         1-9 kg lost - - - - 0.70 (0.53, 0.92) * 
Gregg 2003 (18) 
Overweight, obese 
men & women ‡, ** 
11.5% had DM, 
cancer or CVD. 
8 year  
           >9kg lost - - - - 0.90 (0.64, 1.25) 
No intention to lose weight (73.0% men) 42.2 (9.0) 1,899 106  
Loss  42.6 (9.3) 728 - 1.17 (0.82, 1.66) 
Stable 43.5 (8.7) 586 - 1  (HR adj 11 vars) 
Gain 40.4 (8.7) 585 - 1.58 (1.08, 2.30) † 
Intended to lose weight (52.8% men)a 42.2 (9.0) 1,058 162  
Loss 41.5 (9.4) 398 84 1.87 (1.22, 2.87) † 
Stable 43.4  (8.4) 303 34 0.84 (0.49, 1.48) 
Sørensen 2005:(22) 
Overweight, obese 
men & women II  
 
 
 
Self-reported 
weight and   
Intention of weight 
loss 
Gain 41.9 (8.9) 357 44 0.93 (0.55, 1.56) 
* Significant decrease (p≤ 0.05); † Significant increase (p≤ 0.05); †† Borderline significant decrease (p≈ 0.05); - Not Available Data 
‡ 8 year cumulative mortality rates: Cox proportional hazard model adjusted for 13(+) variables age, sex, ethnicity, initial BMI, smoking, education, self-rated health, diabetes, 
acute and chronic conditions, functional limitations due to cardiovascular disease or cancer, bed days and hospital days. 
§ 5 year mortality relative risk. Includes perioperative deaths in surgery group (0.4%).  Unknown adjustments.  NB follow-up mean 2.5 years.  However, results verified by 
significant Kaplan-Meier survival curves. 
II Cox proportional hazard model adjusted for 11 variables age (in 1981), sex, BMI (in1975), hypertension, smoking, alcohol, physical activity, life satisfaction, work status and 
income.   
** NB if smokers are excluded (n=4957) then only intentional weight loss is significant  
 (HR) Hazard ratio; (RR) Relative Risk; (adj n vars) adjusted for n covariables. 
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Table 5: Mortality rate ratios – Diabetes (DM) or Non insulin dependent diabetes (NIDDM) (The reference group is highlighted for each study) 
Age  All cause Mortality Author year Status Group of interest 
     Mean        (sd) 
Sample size 
Deaths rate ratios (95%CI) 
No weight change (and unknown) 54.5 (6.0) 2,493 980 1  (HR adj 10+ vars) 
Unintentional weight loss  55.6 (5.7) 649 280 0.98 (0.85, 1.13)  
Williamson 
2000(26)Overweight 
people with DM ‡ 
No other pre-
existing illness 
Intentional weight loss  54.5 (6.0) 1,669 561 0.75 (0.67, 0.84) * 
Base 26<BMI<29: 48  (5.8)
lost > 2 BMI -   -
- 
<252 
 
<52 
 
2.02 (1.00, 4.08) †† 
no weight change -  - <581 <35 1  (RR adj 3 vars) 
gain > 2 BMI -   - <159 <14 0.73 (0.23, 2.67) 
Base BMI≥29: 48  (5.6)
lost > 2 BMI -  -
- 
<252 
 
<52 
 
0.84 (0.40, 1.74) 
no weight change   - - <581 <35 1  (RR adj 3 vars) 
Chaturvedi 1995(16) 
People with  
Type 2 DM §, ‡‡ 
Weight change 
intention unknown 
gain > 2 BMI -  - <159 <14 1.74 (0.74, 4.06) 
Not trying to lose weight (55.4% men) 64.2    - 427 -
        Stable/Gain - - - - 1  (HR adj 17 vars) 
       (Lost median 15 pounds) - - - -        1.58 (1.08, 2.31)
 †  
             BMI ≥30 ** - - - -  3.29 (1.55,6.98)
 † 
Gregg 2004(19) 
overweight & obese 
people with DM  II, ** 
No other pre-
existing illness  
             BMI 25-29 ** - - - -         1.20 (0.80,1.81)
 
  Trying to lose weight (36.4% men) 59.9 - 974 - 0.77 (0.61, 0.99) * 
  Stable/Gain - - - - 0.72 (0.55, 0.96) * 
  (Lost median 15 pounds) - - - - 0.83 (0.63, 1.08)  
      
      
      
      
BMI ≥30 ** - - - - 1.17 (0.72, 1.92) 
BMI 25-29 ** - - - - 0.62 (0.46, 0.83) * 
No loss *** - - - - 0.64 (0.42,0.97) * 
Weight loss *** - - - - 0.58 (0.43, 0.84)  * 
* Significant decrease (p≤ 0.05); † Significant increase (p≤ 0.05); †† Borderline significant increase (p approximately 0.05); - Not Available Data 
‡ Proportional hazard model adjusted for 10(+) variables: age, sex, race, smoking, initial BMI, education, drinking, physical activity, disease history and current signs and 
symptoms.  Includes all deaths with diabetes listed as primary, secondary, or tertiary cause of death. 
§ Proportional hazard model to estimate Relative Risk adjusted for 3 variables: age, sex, and duration of diabetes.  
II Cox proportional hazard model adjusted for 17 variables: age, sex, ethnicity, initial BMI, smoking, education, self-rated health, diabetes medication, duration of disease, 
functional limitations, hypertension, heart disease, stroke, retinal disease, neuropathy symptoms, hospital days, and doctors visits. 
** Results extracted from text assumed to have the same adjustments as the main model. 
‡‡ sample size and number of deaths for all weight change categories. (DM) Diabetes Mellitus:  (HR) Hazard ratio: (RR) Relative Risk: (adj n vars) adjusted for n covariables. 
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